This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal.
But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death...
The Democratic Party's presidential hopefuls are diverse in all ways but one -- their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan.
But that's not something they've been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to...
*Featured in Kaiser Health News Morning Briefing*
Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients.
In today’s system, insurers...
Sen. Kamala Harris, D-Calif., wants to ban private health insurance. But if she can't do that outright, she's happy settling for a reform that will eventually take away private health coverage.
Harris, who is pursuing the Democratic nomination for president in 2020, spoke honestly about her...
In “The Wealth of Nations,” the 18th century economist and philosopher Adam Smith observed about the chicanery of some businessmen, “People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in...
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation...
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years.
Although drug...
Washington state Gov. Jay Inslee wants to create a state-run health insurance plan to compete against private coverage on the Evergreen State's Obamacare exchange. This plan, known as a "public option," is a terrible idea. It'd be a boondoggle for taxpayers and open the door to a...
By Henry I. Miller, M.S., M.D. and Jeff Stier
Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. "Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer,...
Congress is poised to consider a bill that would allow Americans to import prescription drugs from Canada. The bill's authors, Sens. Chuck Grassley (R-Iowa) and Amy Klobuchar (D-Minn.), label their effort as a bipartisan push to "help Americans who struggle to pay exorbitant prices for medication."
It's...
Drug price controls will stifle innovation: Pharmaceutical industry R&D is saving lives
This year, 1.7 million Americans will be diagnosed with cancer. For over 600,000 of them, that diagnosis will prove fatal. But there’s hope on the horizon. More Americans are surviving cancer each year, according to a new study from the American Cancer Society. The cancer death...
Democratic 2020 Hopefuls: All Roads Lead To Single-Payer
The Democratic Party's presidential hopefuls are diverse in all ways but one -- their stance on healthcare reform. The front-runners want to eliminate private insurance and put everyone on a government-run plan. But that's not something they've been enthusiastic about revealing to voters. Senator Elizabeth Warren recently refused to...
Don’t blame drug companies for high prices
*Featured in Kaiser Health News Morning Briefing* Today, Type 1 diabetes patients pay twice as much for insulin as they did in 2012. This is outrageous — but drug companies aren’t to blame. The problem is a dysfunctional supply chain that benefits everyone except patients. In today’s system, insurers...
You should absolutely believe Kamala Harris: ‘Medicare for All’ will kill your health insurance
Sen. Kamala Harris, D-Calif., wants to ban private health insurance. But if she can't do that outright, she's happy settling for a reform that will eventually take away private health coverage. Harris, who is pursuing the Democratic nomination for president in 2020, spoke honestly about her...
Do organic farms really produce ‘chemical free, healthier food’?
In “The Wealth of Nations,” the 18th century economist and philosopher Adam Smith observed about the chicanery of some businessmen, “People of the same trade seldom meet together, even for merriment and diversion, but the conversation ends in a conspiracy against the public, or in...
Fostering Transparency In The Pharmaceutical Market
In response to the problem of rising list prices for drugs, elected officials continue to propose counterproductive reforms. Whether it is importing drugs from Canada or indexing U.S. drug prices to the prices charged in other countries, these policies will make the current bad situation...
Medicare price controls would harm patients and workers
Health and Human Services Secretary Alex Azar just released a sweeping proposal that would drastically change how Medicare pays for advanced cancer therapies and other potent medicines. The plan relies on foreign price controls to reduce drug spending by $17 billion over five years. Although drug...
Washington’s rude healthcare awakening
Washington state Gov. Jay Inslee wants to create a state-run health insurance plan to compete against private coverage on the Evergreen State's Obamacare exchange. This plan, known as a "public option," is a terrible idea. It'd be a boondoggle for taxpayers and open the door to a...
Here’s an idea for controlling drug prices: Restore market forces
By Henry I. Miller, M.S., M.D. and Jeff Stier Trump administration officials keep searching for solutions to rising prescription drug prices, which are increasing faster than inflation. "Drug makers and companies are not living up to their commitments on pricing. Not being fair to the consumer,...
Grassley-Klobuchar proposal ushers in dangerous counterfeit drugs
Congress is poised to consider a bill that would allow Americans to import prescription drugs from Canada. The bill's authors, Sens. Chuck Grassley (R-Iowa) and Amy Klobuchar (D-Minn.), label their effort as a bipartisan push to "help Americans who struggle to pay exorbitant prices for medication." It's...